Home
Account
Research Tools & Data
Educate
Contribute
News
ETFs
Sectors
About
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Economic Calendar
Chart School
Tutorials
Learning Center
Submit Article
Join Blog Network
Chat Rooms
Rate Broker
Rate Software
About Us
Contact Us
Advertise With Us
Terms and Conditions
Enter Symbol
Overview
Community Research
Stock Sentiment
Whisper Estimates
Enter Estimates
Company Profile
Technical Charts
Competitors
Analyst Ratings
Analyst Estimates
Sales Estimates
Related News
Blog Articles
Press Releases
Message Board
Option Chain
Financial Ratios
Technicals
SEC Filings
Sector: Medical
Cytokinetics, Incorporated (NASDAQ: CYTK)
3m
6m
1y
2y
Ranking History
This Week
Last Week
Two Weeks Back
Three Weeks Back
Please login to view our current ranking data
Click here to login
No Information
No Information
No Information
Disclaimer
Headlines
Blog Articles
Press Releases
SEC
Cytokinetics to Present at November Healthcare Conferences
Nov 03, 2009 04:01 PM |
CYTK
Cytokinetics, Incorporated Reports Third Quarter 2009 Financial Results
Oct 28, 2009 04:01 PM |
CYTK
Cytokinetics to Announce Third Quarter Results on October 28, 2009
Oct 21, 2009 04:00 PM |
CYTK
Cytokinetics to Present at the Fourth Annual JMP Securities Healthcare Focus Conference
Sep 29, 2009 04:00 PM |
CYTK
Cytokinetics Highlights Progress and Expansion of Development Programs at Today's Research and Development Day
Sep 18, 2009 07:00 AM |
CYTK
Cytokinetics Presents Phase IIa Clinical Trials Data on Omecamtiv Mecarbil at the 2009 Heart Failure Society of America Annual Meeting
Sep 15, 2009 07:30 AM |
AMGN
,
CYTK
Cytokinetics to Host a Research and Development Day on Friday, September 18th
Sep 11, 2009 10:55 AM |
CYTK
Cytokinetics to Present at the NewsMakers in the Biotech Industry Conference
Sep 09, 2009 04:00 PM |
CYTK
,
TMS
,
TRI
Cytokinetics to Present Phase IIa Clinical Trials Data on Omecamtiv Mecarbil at the 2009 Heart Failure Society of America Annual Meeting
Sep 08, 2009 04:00 PM |
CYTK
Cytokinetics Presents Phase IIa Clinical Trials Data Relating to Omecamtiv Mecarbil at the European Society of Cardiology Congress 2009
Aug 31, 2009 07:30 AM |
AMGN
,
CYTK
More..
More..
Cytokinetics Announces Addition to Board of Directors
Nov 06, 2009 07:51 AM |
AMGN
,
ARQL
,
CYTK
Cytokinetics to Present Phase IIa Clinical Trials Data on Omecamtiv Mecarbil at the European Society of Cardiology Congress 2009
Aug 24, 2009 04:00 PM |
CYTK
Cytokinetics, Incorporated Reports Second Quarter 2009 Financial Results
Jul 29, 2009 04:56 PM |
AMGN
,
CYTK
Cytokinetics to Announce Second Quarter Results on July 29, 2009
Jul 22, 2009 04:00 PM |
CYTK
Cytokinetics Announces the Initiation of a First-Time-in-Humans, Phase I Clinical Trial of CK-2017357
Jun 18, 2009 07:30 AM |
CYTK
Cytokinetics to Present at the Eighth Annual Needham Life Sciences Conference
Jun 04, 2009 04:00 PM |
CYTK
Cytokinetics Presents Clinical Data Relating to Ispinesib in Patients With Metastatic Breast Cancer at the 2009 Annual Meeting of the American Society of Clinical Oncology
Jun 02, 2009 07:30 AM |
CYTK
Cytokinetics Announces Non-Clinical Data Relating to GSK-923295 Presented at the 2009 Annual Meeting of the American Society of Clinical Oncology
Jun 01, 2009 04:00 PM |
CYTK
Cytokinetics Announces Presentations of Data From Phase IIa Clinical Trials of CK-1827452 at the 2009 Heart Failure Congress of the European Society of Cardiology
Jun 01, 2009 07:30 AM |
CYTK
Cytokinetics Presents Clinical Data Relating to SB-743921 in Patients With Non-Hodgkin or Hodgkin Lymphoma at the 2009 Annual Meeting of the American Society of Clinical Oncology
May 30, 2009 08:00 AM |
CYTK
More..
Form 4 CYTOKINETICS INC For: Nov 05 Filed by: GAGE L PATRICK (10K)
Nov 06, 2009 02:23 PM
Form 3 CYTOKINETICS INC For: Nov 05 Filed by: GAGE L PATRICK (10K)
Nov 06, 2009 02:22 PM
Form 4 CYTOKINETICS INC For: Oct 22 Filed by: Blum Robert I (10K)
Oct 23, 2009 07:45 PM
Form 4 Blum Robert I For: Oct 08 (10K)
Oct 12, 2009 08:08 AM
Form 4 MORGANS DAVID J JR For: Oct 01 (10K)
Oct 02, 2009 01:13 PM
Form 4 MORGANS DAVID J JR For: Sep 28 (10K)
Sep 29, 2009 01:05 PM
Form 4 Blum Robert I For: Sep 24 (10K)
Sep 25, 2009 07:03 PM
Form 4 MORGANS DAVID J JR For: Sep 21 (10K)
Sep 22, 2009 01:30 PM
Form 4 Blum Robert I For: Sep 10 (10K)
Sep 11, 2009 01:43 PM
Form 4 Sabry James H For: Aug 19 (10K)
Aug 21, 2009 05:37 PM
More..
Analyst Ratings
More Details
Sentiment Survey
Avg. Short Term
Avg. Long Term
Avg. Grade
More Details
Share Performance
Period
CYTK
Compare to S&P
YTD
11.93 %
-2.43 %
4 Weeks
-34.23 %
-34.92 %
12 Weeks
6.33 %
3.69 %
More...
Financial Ratios
Earnings Performance
EPS Growth in Last Quarter:
-114.29 %
EPS Growth in Last Year:
50.00 %
Sales Growth in Last Quarter:
-92.35 %
Sales Growth in Last Quarter:
76.19 %
More...
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##
Fundamental data is provided by
Zacks Investment Research
, market data is provided by
AlphaTrade.
, and Commentary and Press Releases provided by
Quotemedia
